Skip to main content
  • Poster presentation
  • Open access
  • Published:

Innate immune response-mediated late increase in SuPAR in multi-trauma patients


The soluble form of urokinase-type plasminogen activator (suPAR) has been identified as a marker for immune activation and is demonstrated to accurately predict outcome in patients with sepsis or infectious diseases. In multi-trauma patients a considerable immunological response also occurs that is related to multiple organ failure and patient outcome. We investigated the kinetics of suPAR, correlation with the immune response and outcome in multi-trauma patients.


Blood was obtained from adult multi-trauma patients (n = 63) on arrival at the emergency room (ER) of the Radboud University Nijmegen Medical Centre and days 1, 3, 5, 7, 10 and 14 following trauma. Plasma concentrations of TNFα, IL-6, IL-10, IFNγ, IL-8 and MCP-1 were determined by Luminex, and SuPAR concentrations using ELISA. Clinical data were collected from electronic patient files. Concentrations, areas under the curve (AUC) and regression coefficients were statistically analyzed. Spearman correlation coefficients were calculated and differences between survival/nonsurvival groups were analyzed using unpaired Student t tests.


SuPAR values at admission to the ER were higher in nonsurvivors compared with survivors (n= 16), mean ± SEM 4.1 ± 0.6 ng/ml vs. n = 40, 3.0 ± 0.2 ng/ml, P = 0.03). SuPAR levels increased in time. An increase of suPAR did not predict or precede death, however. SuPAR AUC from ER to day 5 tended to correlate with injury severity score (r = 0.5, P = 0.07). Plasma cytokines in the ER did not correlate with suPAR measured at the same time (for example, TNFα: r = 0.2, P = 0.37, IL-10: r = -0.02, P = 0.91), while cytokine concentrations at the ER did correlate with suPAR levels at days 3 (TNFα: r = 0.6, P < 0.01, IL-10: r = 0.5, P = 0.02) and 5 (TNFα: r = 0.7, P < 0.01).


Plasma concentrations of SuPAR measured at admission to the ER are associated with overall survival of multi-trauma patients. Furthermore, suPAR concentrations increased during hospital admission, with most pronounced increases found in patients that suffered more serious injury and related to the innate immune response determined in the ER. These results indicate that suPAR is an innate immune response-induced late mediator in multi-trauma patients.

Author information

Authors and Affiliations


Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Cite this article

Timmermans, K., Kox, M., Vaneker, M. et al. Innate immune response-mediated late increase in SuPAR in multi-trauma patients. Crit Care 17 (Suppl 2), P286 (2013).

Download citation

  • Published:

  • DOI: